Aug 13 (Reuters) - Roche Holding AG ROG.S :
* HEALTH CANADA APPROVES TECENTRIQ® (ATEZOLIZUMAB), FIRST NEW TREATMENT IN 20 YEARS FOR AGGRESSIVE FORM OF LUNG CANCER(1)
* ROCHE CANADA - SAFETY PROFILE OF TECENTRIQ IN COMBINATION WITH CARBOPLATIN & ETOPOSIDE CONSISTENT WITH KNOWN RISKS OF INDIVIDUAL TREATMENT COMPONENTS
* ROCHE CANADA - HEALTH CANADA APPROVED TECENTRIQ IN COMBINATION WITH CARBOPLATIN & ETOPOSIDE